BioHarvest Sciences (TSE:BHSC) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
BioHarvest Sciences reported a remarkable 101% increase in revenue for Q3 2024, reaching over $6.5 million, surpassing management’s expectations. The company’s gross margins improved significantly, and they successfully uplisted to the Nasdaq Global Market. Their VINIA® product line, including a new SuperFood tea, contributed to strong growth and customer expansion.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Paramount (NASDAQ:PARA) Reduces Its Macy’s Thanksgiving Parade Connection
- Ford (NYSE:F) Slides as Trump Threatens to Hit Mexico with Tariffs
- Intel’s (NASDAQ:INTC) CHIPS Act Payout Will Be $7.87 Billion
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
